Literature DB >> 11905826

Autoreactivity by design: innate B and T lymphocytes.

A Bendelac1, M Bonneville, J F Kearney.   

Abstract

Innate B and T lymphocytes are a subset of lymphocytes that express a restricted set of semi-invariant, germ-line-encoded, autoreactive antigen receptors. Although they have long been set apart from mainstream immunological thought, they now seem to represent a distinct immune-recognition strategy that targets conserved stress-induced self-structures, rather than variable foreign antigens. Innate lymphocytes regulate a range of infectious, tumour and autoimmune conditions. New studies have shed light on the principles and mechanisms that drive their unique development and function, and show their resemblance to another subset of innate lymphocytes, the natural killer cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11905826     DOI: 10.1038/35105052

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  142 in total

1.  Splenic immunity and atherosclerosis: a glimpse into a novel paradigm?

Authors:  Joseph L Witztum
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

2.  Ab initio DFT study of bisphosphonate derivatives as a drug for inhibition of cancer: NMR and NQR parameters.

Authors:  Hussein Aghabozorg; Beheshteh Sohrabi; Sara Mashkouri; Hamid Reza Aghabozorg
Journal:  J Mol Model       Date:  2011-06-02       Impact factor: 1.810

Review 3.  Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.

Authors:  Aleksandar K Stanic; Jang-June Park; Sebastian Joyce
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

4.  IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.

Authors:  Christoph J Binder; Karsten Hartvigsen; Mi-Kyung Chang; Marina Miller; David Broide; Wulf Palinski; Linda K Curtiss; Maripat Corr; Joseph L Witztum
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

5.  Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia.

Authors:  Fabio Ghiotto; Franco Fais; Angelo Valetto; Emilia Albesiano; Shiori Hashimoto; Mariella Dono; Hideyuki Ikematsu; Steven L Allen; Jonathan Kolitz; Kanti R Rai; Marco Nardini; Anna Tramontano; Manlio Ferrarini; Nicholas Chiorazzi
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

6.  The inflammatory cytokine IL-18 induces self-reactive innate antibody responses regulated by natural killer T cells.

Authors:  Sara Lind Enoksson; Emilie K Grasset; Thomas Hägglöf; Nina Mattsson; Ylva Kaiser; Susanne Gabrielsson; Tracy L McGaha; Annika Scheynius; Mikael C I Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-01       Impact factor: 11.205

Review 7.  Clinical consequences of defects in B-cell development.

Authors:  Andre M Vale; Harry W Schroeder
Journal:  J Allergy Clin Immunol       Date:  2010-04       Impact factor: 10.793

Review 8.  Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity.

Authors:  Marc Bonneville; Rebecca L O'Brien; Willi K Born
Journal:  Nat Rev Immunol       Date:  2010-06-11       Impact factor: 53.106

9.  Testing the NKT cell hypothesis of human IDDM pathogenesis.

Authors:  Peter T Lee; Amy Putnam; Kamel Benlagha; Luc Teyton; Peter A Gottlieb; Albert Bendelac
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

10.  Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins.

Authors:  Dapeng Zhou; Carlos Cantu; Yuval Sagiv; Nicolas Schrantz; Ashok B Kulkarni; Xiaoyang Qi; Don J Mahuran; Carlos R Morales; Gregory A Grabowski; Kamel Benlagha; Paul Savage; Albert Bendelac; Luc Teyton
Journal:  Science       Date:  2003-12-18       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.